98 related articles for article (PubMed ID: 21995306)
1. Binding to PLA2 may contribute to the anti-inflammatory activity of catechol.
Dileep KV; Tintu I; Mandal PK; Karthe P; Haridas M; Sadasivan C
Chem Biol Drug Des; 2012 Jan; 79(1):143-7. PubMed ID: 21995306
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory property of n-hexadecanoic acid: structural evidence and kinetic assessment.
Aparna V; Dileep KV; Mandal PK; Karthe P; Sadasivan C; Haridas M
Chem Biol Drug Des; 2012 Sep; 80(3):434-9. PubMed ID: 22642495
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of (E)-4-(3,7-dimethylocta-2,6-dienylamino)phenol, a new derivative of 4-nerolidylcatechol.
Lino RC; Martins FI; Florentino IF; Nascimento MV; Galdino PM; Andrade CH; Rezende KR; Menegatti R; Costa EA
J Pharm Pharmacol; 2013 Jan; 65(1):133-41. PubMed ID: 23215696
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening.
Hao W; Hu Y; Niu C; Huang X; Chang CP; Gibbons J; Xu J
Bioorg Med Chem Lett; 2008 Sep; 18(18):4988-92. PubMed ID: 18768317
[TBL] [Abstract][Full Text] [Related]
6. A biophysical approach to phospholipase A2 activity and inhibition by anti-inflammatory drugs.
Gaspar D; Lúcio M; Wagner K; Brezesinski G; Rocha S; Costa Lima JL; Reis S
Biophys Chem; 2010 Nov; 152(1-3):109-17. PubMed ID: 20846779
[TBL] [Abstract][Full Text] [Related]
7. Inverted binding due to a minor structural change in berberine enhances its phospholipase A2 inhibitory effect.
Chandra DN; Abhilash J; Prasanth GK; Sabu A; Sadasivan C; Haridas M
Int J Biol Macromol; 2012 Apr; 50(3):578-85. PubMed ID: 22305795
[TBL] [Abstract][Full Text] [Related]
8. Changes in PLA(2) activity after interacting with anti-inflammatory drugs and model membranes: evidence for the involvement of tryptophan residues.
Gaspar D; Lúcio M; Rocha S; Lima JL; Reis S
Chem Phys Lipids; 2011 May; 164(4):292-9. PubMed ID: 21435339
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.
Singh N; Jabeen T; Pal A; Sharma S; Perbandt M; Betzel C; Singh TP
Proteins; 2006 Jul; 64(1):89-100. PubMed ID: 16596639
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.
Erlandsen H; Flatmark T; Stevens RC; Hough E
Biochemistry; 1998 Nov; 37(45):15638-46. PubMed ID: 9843368
[TBL] [Abstract][Full Text] [Related]
11. Modeling studies on phospholipase A2-inhibitor complexes.
Nirmal N; Praba GO; Velmurugan D
Indian J Biochem Biophys; 2008 Aug; 45(4):256-62. PubMed ID: 18788476
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
14. Effects of petrosaspongiolide R on the surface topology of bee venom PLA(2): a limited proteolysis and mass spectrometry analysis.
Monti MC; Riccio R; Casapullo A
Bioorg Chem; 2009 Feb; 37(1):6-10. PubMed ID: 18945473
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of experimental TPA-induced dermatitis by acetylenic acetogenins is associated with inhibition of PLA₂ activity.
Otuki MF; Schwob O; Silveira Prudente A; Zaltsman I; Meretski S; Segal J; Yedgar S; Rosenblat G
Eur J Pharmacol; 2011 Dec; 672(1-3):175-9. PubMed ID: 22001563
[TBL] [Abstract][Full Text] [Related]
16. The binding mode of cladocoran A to the human group IIA phospholipase A(2).
Monti MC; Chini MG; Margarucci L; Riccio R; Bifulco G; Casapullo A
Chembiochem; 2011 Nov; 12(17):2686-91. PubMed ID: 21953776
[TBL] [Abstract][Full Text] [Related]
17. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
18. Design of more potent squalene synthase inhibitors with multiple activities.
Kourounakis AP; Matralis AN; Nikitakis A
Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
[TBL] [Abstract][Full Text] [Related]
19. Catechol 1,2-dioxygenase from the Gram-positive Rhodococcus opacus 1CP: quantitative structure/activity relationship and the crystal structures of native enzyme and catechols adducts.
Matera I; Ferraroni M; Kolomytseva M; Golovleva L; Scozzafava A; Briganti F
J Struct Biol; 2010 Jun; 170(3):548-64. PubMed ID: 20040374
[TBL] [Abstract][Full Text] [Related]
20. The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process.
Monti MC; Casapullo A; Cavasotto CN; Tosco A; Dal Piaz F; Ziemys A; Margarucci L; Riccio R
Chemistry; 2009; 15(5):1155-63. PubMed ID: 19065693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
